AIMS: Tissue transglutaminase (tTG) is induced in injured and remodelling tissues, and modulates cellular phenotype, while contributing to matrix cross-linking. Our study tested the hypothesis that tTG may be expressed in the pressure-overloaded myocardium, and may regulate cardiac function, myocardial fibrosis and chamber remodelling. METHODS AND RESULTS: In order to test the hypothesis, wild-type and tTG null mice were subjected to pressure overload induced through transverse aortic constriction. Moreover, we used isolated cardiac fibroblasts and macrophages to dissect the mechanisms of tTG-mediated actions. tTG expression was upregulated in the pressure-overloaded mouse heart and was localized in cardiomyocytes, interstitial cells, and in the extracellular matrix. In contrast, expression of transglutaminases 1, 3, 4, 5, 6, 7 and FXIII was not induced in the remodelling myocardium. In vitro, transforming growth factor (TGF)-β1 stimulated tTG synthesis in cardiac fibroblasts and in macrophages through distinct signalling pathways. tTG null mice had increased mortality and enhanced ventricular dilation following pressure overload, but were protected from diastolic dysfunction. tTG loss was associated with a hypercellular cardiac interstitium, reduced collagen cross-linking, and with accentuated matrix metalloproteinase (MMP)2 activity in the pressure-overloaded myocardium. In vitro, tTG did not modulate TGF-β-mediated responses in cardiac fibroblasts; however, tTG loss was associated with accentuated proliferative activity. Moreover, when bound to the matrix, recombinant tTG induced synthesis of tissue inhibitor of metalloproteinases (TIMP)-1 through transamidase-independent actions. CONCLUSIONS: Following pressure overload, endogenous tTG mediates matrix cross-linking, while protecting the remodelling myocardium from dilation by exerting matrix-preserving actions. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Tissue transglutaminase (tTG) is induced in injured and remodelling tissues, and modulates cellular phenotype, while contributing to matrix cross-linking. Our study tested the hypothesis that tTG may be expressed in the pressure-overloaded myocardium, and may regulate cardiac function, myocardial fibrosis and chamber remodelling. METHODS AND RESULTS: In order to test the hypothesis, wild-type and tTG null mice were subjected to pressure overload induced through transverse aortic constriction. Moreover, we used isolated cardiac fibroblasts and macrophages to dissect the mechanisms of tTG-mediated actions. tTG expression was upregulated in the pressure-overloaded mouse heart and was localized in cardiomyocytes, interstitial cells, and in the extracellular matrix. In contrast, expression of transglutaminases 1, 3, 4, 5, 6, 7 and FXIII was not induced in the remodelling myocardium. In vitro, transforming growth factor (TGF)-β1 stimulated tTG synthesis in cardiac fibroblasts and in macrophages through distinct signalling pathways. tTG null mice had increased mortality and enhanced ventricular dilation following pressure overload, but were protected from diastolic dysfunction. tTG loss was associated with a hypercellular cardiac interstitium, reduced collagen cross-linking, and with accentuated matrix metalloproteinase (MMP)2 activity in the pressure-overloaded myocardium. In vitro, tTG did not modulate TGF-β-mediated responses in cardiac fibroblasts; however, tTG loss was associated with accentuated proliferative activity. Moreover, when bound to the matrix, recombinant tTG induced synthesis of tissue inhibitor of metalloproteinases (TIMP)-1 through transamidase-independent actions. CONCLUSIONS: Following pressure overload, endogenous tTG mediates matrix cross-linking, while protecting the remodelling myocardium from dilation by exerting matrix-preserving actions. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Biljana Skrbic; Kristin V T Engebretsen; Mari E Strand; Ida G Lunde; Kate M Herum; Henriette S Marstein; Ivar Sjaastad; Per K Lunde; Cathrine R Carlson; Geir Christensen; Johannes L Bjørnstad; Theis Tønnessen Journal: Cardiovasc Res Date: 2015-02-17 Impact factor: 10.787
Authors: José González-Santamaría; María Villalba; Oscar Busnadiego; Marina M López-Olañeta; Pilar Sandoval; Jessica Snabel; Manuel López-Cabrera; Janine T Erler; Roeland Hanemaaijer; Enrique Lara-Pezzi; Fernando Rodríguez-Pascual Journal: Cardiovasc Res Date: 2015-08-10 Impact factor: 10.787
Authors: Waqas Hanif; Linda Alex; Ya Su; Arti V Shinde; Ilaria Russo; Na Li; Nikolaos G Frangogiannis Journal: Cardiovasc Pathol Date: 2017-06-21 Impact factor: 2.185
Authors: Arti V Shinde; Ya Su; Brad A Palanski; Kana Fujikura; Mario J Garcia; Nikolaos G Frangogiannis Journal: J Mol Cell Cardiol Date: 2018-03-02 Impact factor: 5.000
Authors: Zhuo Wang; Daniel J Stuckey; Colin E Murdoch; Patrizia Camelliti; Gregory Y H Lip; Martin Griffin Journal: Cell Death Dis Date: 2018-04-27 Impact factor: 8.469
Authors: Maria Pia Savoca; Elisa Tonoli; Adeola G Atobatele; Elisabetta A M Verderio Journal: Micromachines (Basel) Date: 2018-10-31 Impact factor: 2.891